BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $264,180 | -17.2% | 7,000 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $318,920 | +12.3% | 7,000 | 0.0% | 0.01% | +7.7% |
| Q1 2023 | $283,920 | -74.7% | 7,000 | -49.8% | 0.01% | -93.3% |
| Q3 2021 | $1,122,000 | -0.1% | 13,945 | 0.0% | 0.20% | +80.6% |
| Q2 2021 | $1,123,000 | +67.9% | 13,945 | +73.8% | 0.11% | +52.1% |
| Q4 2019 | $669,000 | -75.3% | 8,024 | -74.7% | 0.07% | -49.3% |
| Q3 2019 | $2,711,000 | +78.8% | 31,682 | +71.0% | 0.14% | +17.6% |
| Q2 2019 | $1,516,000 | +2.7% | 18,530 | 0.0% | 0.12% | -1.7% |
| Q1 2019 | $1,476,000 | +13.5% | 18,530 | -6.3% | 0.12% | -24.4% |
| Q4 2018 | $1,300,000 | -61.2% | 19,775 | -55.0% | 0.16% | -19.2% |
| Q3 2018 | $3,347,000 | +32.7% | 43,931 | +29.6% | 0.20% | +26.1% |
| Q2 2018 | $2,522,000 | -3.1% | 33,889 | -17.2% | 0.16% | +48.1% |
| Q1 2018 | $2,602,000 | -20.1% | 40,930 | -18.0% | 0.11% | -15.2% |
| Q4 2017 | $3,257,000 | -66.4% | 49,899 | -67.8% | 0.12% | -68.4% |
| Q3 2017 | $9,688,000 | +132.5% | 154,932 | +123.3% | 0.40% | +114.1% |
| Q2 2017 | $4,167,000 | -19.6% | 69,395 | -30.3% | 0.18% | -9.8% |
| Q1 2017 | $5,182,000 | -59.3% | 99,541 | -65.2% | 0.20% | -65.4% |
| Q4 2016 | $12,740,000 | -49.7% | 286,251 | -47.0% | 0.59% | -52.5% |
| Q3 2016 | $25,343,000 | +7038.9% | 539,731 | +6732.0% | 1.25% | +3803.1% |
| Q2 2016 | $355,000 | -98.4% | 7,900 | -98.5% | 0.03% | -97.2% |
| Q1 2016 | $22,070,000 | +8.0% | 535,534 | 0.0% | 1.14% | +11.2% |
| Q4 2015 | $20,430,000 | +8137.9% | 535,534 | +6678.9% | 1.02% | +7776.9% |
| Q3 2015 | $248,000 | -40.2% | 7,900 | +33.9% | 0.01% | -38.1% |
| Q2 2015 | $415,000 | +2.7% | 5,900 | 0.0% | 0.02% | +10.5% |
| Q1 2015 | $404,000 | -90.2% | 5,900 | -89.3% | 0.02% | -89.8% |
| Q4 2014 | $4,107,000 | +870.9% | 55,375 | +838.6% | 0.19% | +830.0% |
| Q3 2014 | $423,000 | -0.5% | 5,900 | 0.0% | 0.02% | +5.3% |
| Q2 2014 | $425,000 | -85.3% | 5,900 | -85.0% | 0.02% | -91.1% |
| Q1 2014 | $2,894,000 | +609.3% | 39,273 | +565.6% | 0.21% | +791.7% |
| Q4 2013 | $408,000 | -91.0% | 5,900 | -90.9% | 0.02% | -93.0% |
| Q2 2013 | $4,548,000 | – | 65,169 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |